Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal
European Journal of Clinical Microbiology & Infectious Diseases · 2024-07 · 43 (7) · 1297-1308
DOI: 10.1007/s10096-024-04789-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 02.05.2024. Verfasst von Corrado Minetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Anti-Bacterial Agents, Legionella pneumophila, Azithromycin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Saúde Dr. Ricardo Jorge.
Abstract (Originalsprache)
Backgroud Although not fully investigated, studies show that Legionella pneumophila can develop antibiotic resistance. As there is limited data available for Portugal, we determined the antibiotic susceptibility profile of Portuguese L. pneumophila serogroup 1 (LpnSg1) isolates against antibiotics used in the clinical practice in Portugal.
Methods
Minimum inhibitory concentrations (MICs) were determined for LpnSg1 clinical ( n = 100) and related environmental ( n = 7) isolates, collected between 2006–2022 in the context of the National Legionnaire´s Disease Surveillance Programme, against azithromycin, clarithromycin, erythromycin, levofloxacin, ciprofloxacin, moxifloxacin, rifampicin, doxycycline, tigecycline, and amoxicillin/clavulanic acid, using three different assays. Isolates were also PCR-screened for the presence of the lpeAB gene.
Results
Twelve isolates had azithromycin MICs above the EUCAST tentative highest WT MIC, 9 of which were lpeAB negative; for erythromycin and clarithromycin, all isolates tested within the susceptible range. The number of isolates with MICs above the tentative highest WT MIC for the remaining antibiotics was: ciprofloxacin: 7; levofloxacin: 17; moxifloxacin: 8; rifampicin: 11; doxycycline: 82; tigecycline: 4. EUCAST breakpoints are not available for amoxicillin/clavulanic acid. We estimated the ECOFFs and one isolate had a MIC eightfold higher than the E-test ECOFF. Additionally, a clinical isolate generated three colonies growing on the E-test inhibition zone that resulted in MICs fourfold higher than for the parental isolate.
Conclusions
We report, for the first time, elevated MICs against first-line and other antibiotics (including azithromycin, fluoroquinolones and amoxicillin/clavulanic acid commonly used to treat pneumonia patients in Portugal) in Portuguese L. pneumophila strains. Results point towards decreased susceptibility in circulating strains, justifying further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal.
- ECDC Fellowship Programme, Public Health Microbiology Path (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
- Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
- Water Microbiology Laboratory, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal.
- National Reference Laboratory for Legionella, National Institute of Health Doctor Ricardo Jorge (INSA), Lisbon, Portugal. paulo.goncalves@insa.min-saude.pt.
Förderung
- Instituto Nacional de Saúde Dr. Ricardo Jorge
Zitieren
APA
Minetti, C., Barton, R., Farley, C., Spiller, O. B., Rodrigues, R., & Gonçalves, P. (2024). Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal. European Journal of Clinical Microbiology & Infectious Diseases, 43(7), 1297-1308. https://doi.org/10.1007/s10096-024-04789-9
Vancouver
Minetti C, Barton R, Farley C, Spiller OB, Rodrigues R, Gonçalves P. Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(7):1297-1308. doi:10.1007/s10096-024-04789-9
BibTeX
@article{Minetti2024,
author = {Minetti, Corrado and Barton, Rachael and Farley, Caitlin and Spiller, Owen Brad and Rodrigues, Raquel and Gonçalves, Paulo},
title = {Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
volume = {43},
number = {7},
pages = {1297--1308},
doi = {10.1007/s10096-024-04789-9}
}
EUVIMED